Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2023C509 Product name: sacituzumab govitecan

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
2023C/509
Type:
Certificate
SPC type:
Medical
Basic patent number:
211765458
Status:
Open & Published
Publication number:
2023C509
1rst applicant's nationality:
Procedural language:
Dutch

Marketing authorization

Marketing authorization number:
EU/1/21/1592
Marketing authorization type:
National/EU
Designates country:
No
Marketing authorization date:
23/11/2021
Marketing authorization status:
Accepted
Marketing authorization country:
Belgium (BE)

Dates

Filing date:
20/02/2023
First marketing authorization date:
23/11/2021
Grant date:
Activation date:
BE Publication date:
21/02/2023
Lapsed date:
Expiration date (if granted and all annual fees paid):
Basic SPC Expiration (if granted and all annual fees paid):
02/12/2034
SPC/SPC Extension Expiration (if granted and all annual fees paid):
02/12/2034
Rejection date:
Withdrawal date:

Applicant

1

Name:
Immunomedics, Inc.
Legal Form:
From:
26/01/2024
Address:
c/o Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA 94404, United States (US)
To:

2

Name:
Immunomedics Inc.
Legal Form:
Inc.
From:
21/02/2023
Address:
300 American Road, 07950, Morris Plains, New Jersey, United States (US)
To:
26/01/2024

Agent

1

Name:
GEVERS PATENTS
Legal Form:
From:
08/02/2024
Address:
De Kleetlaan 7A, 1831, DIEGEM, Belgium (BE)
To:

2

Name:
GEVERS PATENTS
Legal Form:
From:
21/02/2023
Address:
Holidaystraat 5, 1831, DIEGEM, Belgium (BE)
To:
08/02/2024

Publication

Bulletin

1

Bulletin heading:
SPC
Journal edition number:
2023/04
Publication date:
06/03/2023
Description:
Contains data concerning applications for- or granted Supplementary Protection Certificates

2

Bulletin heading:
CO
Journal edition number:
2024/04
Publication date:
04/03/2024
Description:
Contains data concerning registered assignments or changes of the names of applicants and holders

Deed

Change of owner(s)

Change Kind / Decision Type:
Change of owner(s) name
Deed number:
RC2024100063A
Registration date:
26/01/2024
License effective date:
License expiration date:
Scope of license:
Deed filer:
NLO BVBA
Bulletin edition number:
Text:
correctie van de naam + adreswijziging
Country code:
Updated license number:
Terminated license number:

Removed pledgee

Name:
Address:

Changed pledgee

Name:
Address:

Removed usufructuary

Name:
Address:

Added usufructuary

Name:
Address:

Changed usufructuary

Name:
Address:

Annual fee

Annual fee(s) Due Date:
31/12/2029
Annual fee number:
21
Annual fee amount:
650 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type
20/02/2023 Abstract Product Characteristics Abstract of the characteristics of the product 35 PDF /2/6/5/5/8/0722285562/docs/2023c509_0_abstractproductcharacteristics_20230221_084547252.pdf
20/02/2023 Marketing Authorization 1st Marketing Authorization (EU) 3 PDF /2/6/5/5/8/0722285562/docs/2023c509_1_marketingauthorization_20230221_084547078.pdf
20/02/2023 General Document Other 4 PDF /2/6/5/5/8/0722285562/docs/2023c509_2_generaldocument_20230221_084546868.pdf
20/02/2023 MA Official Publication Official Publication of 1st Marketing Authorization 12 PDF /2/6/5/5/8/0722285562/docs/2023c509_3_maofficialpublication_20230221_084547478.pdf
20/02/2023 Power Of Attorney Power of attorney 1 PDF /2/6/5/5/8/0722285562/docs/2023c509_4_powerofattorney_20230221_084548096.pdf
20/02/2023 Application Form 4 PDF /2/6/5/5/8/0722285562/docs/2023c509_5_applicationform_20230221_084548371.pdf
21/02/2023 Publication I1 1 PDF /2/6/5/5/8/0722285562/docs/2023c509_6_i1document_20230221_093249094.pdf
21/02/2023 Outgoing Correspondence 2 PDF /2/6/5/5/8/0722285562/docs/2023c509_7_outgoingcorrespondence_20230308_100946585.pdf
26/01/2024 Request For Change Free translation of the deed or extract 2 PDF /2/6/5/5/8/0722285562/docs/2023c509_8_rfc_20240127_084554572.pdf
26/01/2024 Request For Change Power of attorney deed 1 PDF /2/6/5/5/8/0722285562/docs/2023c509_9_rfc_20240127_084554719.pdf
26/01/2024 Request For Change Letter and/or Form requesting a change in the Register 3 PDF /2/6/5/5/8/0722285562/docs/2023c509_10_rfc_20240127_084554850.pdf
26/01/2024 Incoming Correspondence (Email) Cover letter 1 PDF /2/6/5/5/8/0722285562/docs/2023c509_11_incomingcorrespondenceelectronic_20240127_084555009.pdf
26/01/2024 Outgoing Correspondence 1 PDF /2/6/5/5/8/0722285562/docs/2023c509_12_outgoingcorrespondence_20240127_084554318.pdf
26/01/2024 Request For Change Deed or extract allowing the change 2 PDF /2/6/5/5/8/0722285562/docs/2023c509_13_rfc_20240127_084554428.pdf
08/02/2024 Request For Change Letter and/or Form requesting a change in the Register 2 PDF /2/6/5/5/8/0722285562/docs/2023c509_14_rfc_20240425_085642791.pdf